VA Asthma Ratings in 2026: PFTs and Inhaler Use

A daily asthma inhaler can support a 30% VA disability rating, even when pulmonary function tests look normal. The VA evaluates asthma under Diagnostic Code 6602, using medication needs, PFT results, corticosteroid treatment, and the frequency of serious flare-ups.

Many veterans focus on one test result and miss stronger evidence in their prescription history and treatment records. As of July 2026, the right evidence can show both how asthma connects to military service and how severely it limits daily life.

Key Takeaways

• VA asthma ratings under Diagnostic Code 6602 are 10%, 30%, 60%, or 100%.
• Daily bronchodilator or inhaled anti-inflammatory therapy can support a 30% rating.
• FEV-1 and FEV-1/FVC percentages are the main PFT measurements for asthma ratings.
• Three or more systemic corticosteroid courses in one year, or monthly visits for exacerbations, can support 60%.
• A current diagnosis, service connection evidence, and records showing severity are all needed for a strong claim.

How VA Asthma Ratings Work Under Diagnostic Code 6602

The VA rates bronchial asthma under 38 C.F.R. § 4.97, Diagnostic Code 6602. The schedule has four rating levels: 10%, 30%, 60%, and 100%. Asthma does not have separate 20%, 40%, 50%, 70%, 80%, or 90% ratings under this diagnostic code.

The rating schedule uses an “or” structure. That means you may qualify for a rating through PFT results, medication requirements, steroid treatment, or serious exacerbations. You don’t need to satisfy every requirement in a rating level.

Rating	PFT measurements	Medication or treatment evidence
10%	FEV-1 or FEV-1/FVC at 71% to 80% predicted	Intermittent inhalational or oral bronchodilator therapy
30%	FEV-1 or FEV-1/FVC at 56% to 70% predicted	Daily bronchodilator therapy or daily inhaled anti-inflammatory medication
60%	FEV-1 or FEV-1/FVC at 40% to 55% predicted	At least monthly physician visits for exacerbations, or at least three systemic corticosteroid courses per year
100%	FEV-1 or FEV-1/FVC below 40% predicted	Daily high-dose systemic corticosteroids or immunosuppressive medication, or more than one attack per week with respiratory failure

The VA generally assigns the highest level supported by the evidence. For example, a veteran with an FEV-1 above 70% may still qualify for 30% if the medical record shows daily inhaled therapy.

A veteran with intermittent albuterol use and normal PFTs may qualify for 10%. However, the prescription instructions and treatment history must show intermittent bronchodilator therapy for asthma. The VA cannot properly rate the condition based on a medication name alone.

The DC 6602 asthma rating criteria provide a useful comparison of the PFT and treatment thresholds. The controlling authority remains the VA rating schedule and the evidence in your claim file.

When Inhaler Use Supports a 30% Rating

Inhaler use often becomes the deciding evidence when PFT results don’t show a high level of impairment. Under DC 6602, daily inhalational or oral bronchodilator therapy supports a 30% rating. Daily inhaled anti-inflammatory medication also meets the 30% medication standard.

Common asthma medications include:

• Albuterol, a short-acting bronchodilator often used as a rescue medication.
• Advair, which combines fluticasone and salmeterol.
• Symbicort, which combines budesonide and formoterol.
• Fluticasone and budesonide, inhaled anti-inflammatory medications.

The brand name matters less than the active ingredients, prescribed frequency, and reason for treatment. A veteran should identify whether the medication treats asthma, another respiratory condition, or both.

A prescription that says “use daily” provides stronger evidence than a medication list that only shows the drug name. Treatment notes can also explain whether the veteran needs daily maintenance therapy, uses a rescue inhaler during flare-ups, or requires both.

The VA may distinguish between these situations:

• A rescue inhaler used only during occasional symptoms may support 10%.
• A bronchodilator taken or used every day may support 30%.
• A daily inhaled corticosteroid or other inhaled anti-inflammatory may support 30%.
• Oral prednisone or another systemic corticosteroid may support 60% or 100%, depending on frequency and dosage.

A veteran shouldn’t assume that daily rescue inhaler use automatically appears in the record. Tell the treating provider how often you use the medication, what triggers symptoms, and whether symptoms return when you miss a dose. Pharmacy records can help show regular refills, but clinical notes should explain the medical need.

The asthma VA rating evidence guide also discusses how medication history can affect the assigned percentage. Medical records remain more persuasive when they connect the prescription to documented asthma symptoms and treatment.

What PFT Results Mean for an Asthma Claim

Pulmonary function testing measures how well the lungs move air. For VA asthma ratings, the two most important measurements are FEV-1 and FEV-1/FVC.

FEV-1 means forced expiratory volume in one second. It measures how much air you force out during the first second of a full exhalation. FVC means forced vital capacity, which is the total amount of air you exhale after taking a full breath. The FEV-1/FVC ratio compares those two measurements.

The report usually expresses results as a percentage of the predicted value. Predicted values account for factors such as age, height, and sex. Raw numbers in liters don’t tell the whole story, so review the percentage columns carefully.

For asthma under DC 6602:

• 71% to 80% predicted supports 10%.
• 56% to 70% predicted supports 30%.
• 40% to 55% predicted supports 60%.
• Below 40% predicted supports 100%.

The VA generally looks at post-bronchodilator results when applying respiratory rating criteria. The regulations provide exceptions, including situations where the examiner explains why post-bronchodilator testing isn’t appropriate or where the post-bronchodilator result is poorer than the pre-bronchodilator result.

A complete PFT report may include pre- and post-bronchodilator values. It should also identify the date, testing method, predicted percentages, and the examiner’s interpretation. Missing pages or unclear reports can make it harder to determine which result the VA used.

PFTs can vary from one day to another. Asthma may be controlled on the day of testing, especially if medication was taken before the appointment. A normal or near-normal PFT does not automatically disprove asthma or eliminate a possible rating based on daily medication.

A VA examiner should also address the history of flare-ups, treatment, and functional effects. The VA’s published decision involving asthma rating evidence illustrates why the complete record matters, not one isolated medical number.

Evidence That Can Increase or Protect the Rating

PFTs and inhaler records are important, but they aren’t the only evidence that matters. Asthma severity often appears in the timeline of treatment rather than in one office visit.

Medical records should show the date and nature of exacerbations. They may include urgent care visits, emergency department treatment, hospitalization, nebulizer treatments, steroid prescriptions, and instructions to increase medication during a flare-up.

Systemic corticosteroids are different from inhaled corticosteroids. Oral prednisone and injected steroids are systemic treatments. Under DC 6602, at least three courses in one year can support 60%. Daily high-dose systemic corticosteroids or immunosuppressive medication can support 100%.

Routine follow-up appointments don’t necessarily count as monthly physician visits for exacerbations. The records should show that the visits occurred because of asthma flare-ups or the care required to control them.

Useful evidence may include:

• Pulmonology and allergy records.
• Primary care treatment notes.
• Medication lists with dose and frequency.
• Pharmacy refill records.
• Emergency room and hospital records.
• Steroid prescriptions and discharge instructions.
• Lay statements describing missed work, nighttime symptoms, and activity limits.
• A completed Respiratory Conditions Disability Benefits Questionnaire, when appropriate.

A personal statement can fill gaps in the medical record, but it should use concrete details. Explain how often you wake at night, how far you can walk before becoming short of breath, how often you miss work, and how frequently you need a rescue inhaler.

The VA may also consider whether asthma affects ordinary activities. Difficulty climbing stairs, exercising, working outdoors, sleeping, or tolerating heat and humidity can help describe functional loss. These details don’t replace the regulatory criteria, but they give the examiner a clearer picture of the condition.

Establishing Service Connection for Asthma

A high rating cannot be awarded unless the VA first recognizes asthma as service connected. This requires evidence of a current asthma diagnosis, an in-service event or exposure, and a connection between the two.

Service records may document respiratory complaints, treatment, duty restrictions, environmental exposures, or repeated sick-call visits. Relevant exposure evidence can include burn pits, particulate matter, toxic chemicals, dust, smoke, industrial fumes, and other conditions associated with a veteran’s duties or deployment.

Some veterans may qualify for a presumption related to qualifying service and the timing of an asthma diagnosis. The PACT Act expanded certain presumptions involving particulate matter and respiratory conditions. Eligibility depends on the veteran’s service location, dates, diagnosis, and other legal requirements. A presumption can reduce the need for a direct medical nexus, but it doesn’t remove the need to prove the diagnosis and rating level.

Direct service connection remains available when a presumption doesn’t apply. For example, a veteran may rely on service treatment records showing symptoms, a medical opinion linking current asthma to an in-service exposure, and post-service records showing continued treatment.

The evidence should also separate asthma from other respiratory diagnoses. COPD, chronic bronchitis, allergic rhinitis, sinusitis, and sleep apnea have different rating rules. A veteran may have more than one service-connected respiratory condition, but the VA must avoid compensating the same symptoms twice.

For Florida veterans, deployment records and treatment may come from several states or federal facilities. Gather records from VA clinics, private pulmonologists, urgent care centers, and hospitals. A claim becomes easier to evaluate when the evidence shows a continuous treatment history instead of isolated documents.

Common Problems With VA Asthma Claims

Many asthma claims fail because the evidence answers only one part of the case. A PFT may establish severity, but it doesn’t prove service connection. A service record may show exposure, but it doesn’t establish the current rating.

One common problem is treating a single normal PFT as conclusive. Asthma symptoms fluctuate, and medication can improve test results. The claim should include the medication regimen and the full treatment history.

Another issue is vague inhaler evidence. A medication list may show albuterol without explaining how often it is needed. Ask the provider to document the prescribed frequency and whether the treatment is for asthma.

Steroid records also require careful review. An inhaled corticosteroid is not the same as a systemic corticosteroid course. The record should identify the drug, route, dose, duration, and reason for treatment.

Some VA examinations omit important facts. The examiner may not discuss daily inhaler therapy, may misread the medication history, or may fail to explain why the PFT results accurately reflect the condition. Compare the examination report with your treatment records and prescription instructions.

If the VA denies service connection or assigns too low a percentage, read the decision letter closely. It should explain which element the VA found lacking. The reason may involve the diagnosis, service connection, severity, effective date, or the weight given to medical evidence.

Preserve the one-year deadline shown in the decision letter. A delay can limit review options or affect the effective date of benefits.

Choosing an Appeal Path After a Denial

The best review option depends on what went wrong and what evidence is available. Under the Appeals Modernization Act, common options include a Supplemental Claim, Higher-Level Review, and Board Appeal.

A Supplemental Claim allows you to submit new and relevant evidence. This may fit an asthma case where the original record lacked medication instructions, updated PFT results, steroid records, or a medical nexus opinion.

A Higher-Level Review asks a more senior VA reviewer to examine the existing record for an error. New evidence generally isn’t accepted in this lane, so it may not fit when the claim needs additional medical documentation.

A Board Appeal sends the case to the Board of Veterans’ Appeals. Veterans can choose a Direct Review, Evidence Submission, or Hearing docket. The Board may be appropriate when the dispute involves a complex medical history, conflicting evidence, or repeated denials.

You can review how to select a VA appeal path when deciding which lane fits the record. If the VA has already denied the claim, the steps to appeal a denied VA claim can help organize the next filing.

An attorney or accredited representative can compare the decision’s reasoning with the medical evidence. That review may identify an overlooked daily inhaler prescription, a missing steroid course, an inadequate examination, or a service-connection error.

The effective date also matters. If a later appeal succeeds, the date of benefits may depend on the original claim, the review request, and the evidence. Keep every VA notice and submit the proper review request before the applicable deadline.

Building a Strong Asthma Evidence File

Start with the VA decision, then identify each reason for denial or the assigned percentage. Create a medical timeline that lists diagnoses, PFT dates, medication changes, urgent visits, emergency treatment, and steroid courses.

Next, obtain complete records rather than relying on medication summaries. A full pulmonology note may explain daily treatment that a pharmacy printout doesn’t show. Include PFT pages with predicted percentages and post-bronchodilator results.

Your evidence file should also contain service records and a clear explanation of the connection to service. If the claim involves toxic exposure or deployment, gather personnel records, deployment information, and medical opinions that address the actual exposure and diagnosis.

Finally, describe the condition in ordinary terms. Explain what happens during an attack, how often symptoms interrupt sleep or work, and what treatment you need to remain functional. Specific dates and frequency are more useful than statements that asthma is “severe.”

Conclusion

VA asthma ratings in 2026 depend on the complete medical picture. PFT results matter, but daily inhaler therapy, systemic steroid courses, exacerbation visits, and functional limitations can support a higher evaluation when the test numbers don’t tell the whole story.

The strongest claim connects three points: a current asthma diagnosis, a service-related cause, and evidence that matches the rating criteria. When those records are organized before filing or appealing, a single normal breathing test is less likely to obscure the severity of the condition.